Analyst Ratings for Intercept Pharmaceuticals (ICPT) [Buys]
ICPT Rating Summary
ICPT Price Target Summary
- Highest: $19.00 (RBC Capital)
- Lowest: $12.00 (Goldman Sachs)
- Average: $17.14
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$17.14 (-9.8%)
* Over Last 12-Mos
Rating Score: 3.9 / 10 Percentile Rank: 38%
Rating Score: 3.9 / 10 Percentile Rank: 38%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
11/10/2020 | Baird » Updated 9/26/2023 |
Brian Skorney | Upgrade | Outperform (Neutral) |
19.00 (18.00) |
28.15 (19.00) |
-32.5% | Details |
7/31/2020 | Piper Sandler » Updated 6/7/2022 |
Yasmeen Rahimi | New Coverage | Overweight (N/A) |
82.00 (N/A) |
45.60 (19.00) |
-58.33% | Details |